Teva Pharmaceutical Industries Limited Share Price TEL AVIV STOCK EXCHANGE
Stocks
TEVA
IL0006290147
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,960.00 ILa | +2.62% |
|
+14.20% | +8.42% |
| 07-30 | Teva CEO on Drug Pipeline, Direct Listing on NYSE | MT |
| 07-29 | Teva Pharmaceutical Industries Limited Reports Unaudited Consolidated Impairment Charges for the Second Quarter Ended June 30, 2026 | CI |
| Market Cap | 41.26B 0 35.84B 33.28B 30.69B 57.82B 3,939B 58.87B 394B 154B 1,956B 155B 152B 6,579B | P/E 2026 * |
47.5x | P/E 2027 * | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 53.14B 0 46.16B 42.86B 39.53B 74.46B 5,073B 75.81B 507B 199B 2,520B 200B 195B 8,473B | EV / Sales 2026 * |
3.2x | EV / Sales 2027 * | 2.88x |
| Free-Float |
88.61% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Teva Pharmaceutical Industries Limited
| 1 day | +2.43% | ||
| 1 week | +14.20% | ||
| Current month | +11.21% | ||
| 1 month | +11.21% | ||
| 3 months | +5.39% | ||
| 6 months | +8.32% | ||
| Current year | +8.42% |
| 1 week | 9,450 | 10,970 | |
| 1 month | 9,396 | 10,970 | |
| Current year | 8,860 | 11,350 | |
| 1 year | 5,305 | 11,350 | |
| 3 years | 3,002 | 11,350 | |
| 5 years | 2,383 | 11,350 | |
| 10 years | 2,175 | 20,860 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 31/12/2022 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 21/12/2019 |
Matthew Shields
COO | Chief Operating Officer | 52 | 02/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 31/12/2008 |
Sol Barer
CHM | Chairman | 78 | 05/02/2017 |
Rosemary Crane
BRD | Director/Board Member | 65 | 31/08/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.62% | +14.20% | - | - | 41.26B | ||
| -4.55% | -2.61% | +51.95% | +151.91% | 1,030B | ||
| -3.66% | -1.33% | +52.95% | +46.62% | 617B | ||
| -2.24% | +0.19% | +35.97% | +70.64% | 455B | ||
| +0.74% | +0.42% | +38.70% | +31.78% | 350B | ||
| +0.87% | +0.82% | +35.83% | +40.49% | 299B | ||
| +0.85% | +1.33% | +13.37% | +14.77% | 265B | ||
| +0.07% | +3.23% | +5.23% | -39.40% | 225B | ||
| 0.00% | +4.34% | +28.63% | +64.00% | 209B | ||
| -1.09% | +0.32% | +14.40% | +70.80% | 163B | ||
| Average | -0.18% | +4.83% | +30.78% | +50.18% | 401.41B | |
| Weighted average by Cap. | -0.62% | +4.87% | +38.70% | +72.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.58B 0 14.4B 13.38B 12.34B 23.24B 1,583B 23.66B 158B 62B 786B 62.27B 60.91B 2,644B | 17.3B 0 15.03B 13.96B 12.87B 24.25B 1,652B 24.69B 165B 64.7B 820B 64.98B 63.56B 2,759B |
| Net income | 1.14B 0 991M 920M 848M 1.6B 109B 1.63B 10.89B 4.26B 54.07B 4.28B 4.19B 182B | 2.34B 0 2.03B 1.88B 1.74B 3.27B 223B 3.33B 22.32B 8.74B 111B 8.78B 8.58B 373B |
| Net Debt | 11.88B 0 10.32B 9.58B 8.84B 16.64B 1,134B 16.94B 113B 44.41B 563B 44.6B 43.63B 1,894B | 8.61B 0 7.48B 6.95B 6.41B 12.07B 822B 12.28B 82.23B 32.2B 408B 32.34B 31.63B 1,373B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | ILA 10,960.00 | +2.62% | 360,578 |
| 30/07/26 | ILA 10,680.00 | +1.14% | 1,803,433 |
| 29/07/26 | ILA 10,560.00 | +10.17% | 2,354,552 |
| 28/07/26 | ILA 9,585.00 | +0.89% | 831,774 |
| 27/07/26 | ILA 9,500.00 | -0.84% | 1,193,392 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions


















